LGP Stock Overview
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Little Green Pharma Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.13 |
| 52 Week High | AU$0.17 |
| 52 Week Low | AU$0.077 |
| Beta | 1.03 |
| 11 Month Change | -18.75% |
| 3 Month Change | 39.78% |
| 1 Year Change | 6.12% |
| 33 Year Change | -80.15% |
| 5 Year Change | n/a |
| Change since IPO | -63.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| LGP | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -11.8% | 1.5% |
| 1Y | 6.1% | 39.8% | 17.2% |
Return vs Industry: LGP underperformed the Australian Pharmaceuticals industry which returned 43.4% over the past year.
Return vs Market: LGP underperformed the Australian Market which returned 17.7% over the past year.
Price Volatility
| LGP volatility | |
|---|---|
| LGP Average Weekly Movement | 17.2% |
| Pharmaceuticals Industry Average Movement | 11.9% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: LGP's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: LGP's weekly volatility has increased from 12% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 94 | Paul Long | www.littlegreenpharma.com |
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.
Little Green Pharma Ltd Fundamentals Summary
| LGP fundamental statistics | |
|---|---|
| Market cap | AU$39.23m |
| Earnings (TTM) | -AU$8.15m |
| Revenue (TTM) | AU$25.63m |
1.5x
P/S Ratio-4.8x
P/E RatioIs LGP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LGP income statement (TTM) | |
|---|---|
| Revenue | AU$25.63m |
| Cost of Revenue | AU$12.51m |
| Gross Profit | AU$13.12m |
| Other Expenses | AU$21.27m |
| Earnings | -AU$8.15m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | 51.18% |
| Net Profit Margin | -31.81% |
| Debt/Equity Ratio | 4.5% |
How did LGP perform over the long term?
See historical performance and comparison